上週31人染新冠亡!30歲男急診當天病逝 KP.2恐成主流變異株 | CTWANT | LINE TODAY

https://liff.line.me/1454987169-1WAXAP3K/v2/article/JPrBGVX?utm_source=lineshare

上週31人染新冠亡!30歲男急診當天病逝 KP.2恐成主流變異株 | CTWANT | LINE TODAY

疾病管制署今(7日)表示,國內COVID-19疫情上週(4/30-5/6)新增229例COVID-19本土確定病例(併發症),較前一週(4/23-4/29)新增185例上升,累積併發症個案中65歲以上長者占79%;另上週新增31例死亡病例,較前一週新增15例上升,累積死亡個案中65歲以上長者占90%,疫情仍有傳播風險。 疾管署說明,國內新冠XBB疫苗迄今已累計接種266.8萬人次,全國接種率11.

https://liff.line.me/1454987169-1WAXAP3K/v2/article/JPrBGVX?utm_source=lineshare
Past 31 days
Total Visit: 10
There is 1 fact-checking reply to the message
ROo_0y mark this message contains true information
originally written by ROo_0y
疾管署預防醫學辦公室主任林詠青說,上周死亡個案有貧血、癲癇等病史,疾管署副署長曾淑慧表示,KP.2變異株(又稱FLiRT變異株),研究顯示KP.2傳播力約JN.1的1.2倍,呼籲未施打接種新冠XBB疫苗第1劑者,盡速接種;而與前1劑疫苗間隔已達12周、84天的65歲以上長者,應盡速再接種第2劑,提升免疫防護力。

References

https://udn.com/news/story/7266/7948312

30多歲男染新冠就醫當天病逝 疾管署:KP.2變異株恐成主流 | 聯合新聞網

衛福部疾管署今公布,國內新冠疫情上周新增229例本土確定病例,較前一周新增185例,累積併發症個案中65歲以上長者占79...

https://udn.com/news/story/7266/7948312

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Automated analysis from ChatGPT
Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙